Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02260141 · ClinicalTrials.gov registry record · NA
Treating Alzheimer's and Dementia With D-ribose
A NA study, sponsored by Practitioners Alliance Network.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02260141: Clinical Trial NA study, sponsored by Practitioners Alliance Network.
NCT02260141 is a NA study that was terminated before completion, run by Practitioners Alliance Network. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02260141, a NA study, was terminated before completion, sponsored by Practitioners Alliance Network.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
To study the effectiveness of d-ribose in treating Alzheimer's and Dementia
Interventions
- DIETARY_SUPPLEMENT d-ribose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-10 |
| Phase | NA |
Why NCT02260141 stopped before completion
NCT02260141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which d-ribose is the first listed.
NCT02260141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02260141 about?
NCT02260141 is a clinical study titled "Treating Alzheimer's and Dementia With D-ribose". To study the effectiveness of d-ribose in treating Alzheimer's and Dementia
What is the current status of trial NCT02260141?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2014-09. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02260141?
The interventions under investigation include: d-ribose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02260141?
This trial is sponsored by Practitioners Alliance Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02260141's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia